<p>Tayyaba Hasan of Harvard University in the U.S. will work to design a conjugate which will attach to the GP63 enzyme of the Leishmania parasite. This therapy will consist of a lightactivatable, non-toxic chemical that will be activated by a light source, killing the parasite but leaving surrounding cells intact.</p>


Tayyaba Hasan of Harvard University in the U.S. will work to design a conjugate which will attach to the GP63 enzyme of the Leishmania parasite. This therapy will consist of a lightactivatable, non-toxic chemical that will be activated by a light source, killing the parasite but leaving surrounding cells intact.

GP63-Targeted Conjugate for Photodynamic Therapy of Visceral Leishmaniasis

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

.css-1nxq281{overflow:hidden;display:inline-block;}.css-1nxq281 span{display:inline-block;}Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

Great ideas come from everywhere.